Literature DB >> 19430930

The role of Toll-like receptor signaling in human immunodeficiencies.

Hanna Suhir1, Amos Etzioni.   

Abstract

Through the last decade, clinical immunology has witnessed a considerable progress in understanding the role of the innate immunity in human host defense, with Toll-like receptors (TLRs) being the most extensively innate immune receptors investigated. Growing literature documents the relevance of TLR signaling pathways to human disease, revealing a small, but expanding, group of new monogenic primary immunodeficiencies, in patients with various infectious diseases, previously considered as of unexplained "idiopathic" origin. Herein, we review these recently described deficiencies. Autosomal recessive IRAK-4 and myeloid differentiation factor 88 deficiencies were reported in 2003 and 2008, respectively, conferring predisposition to pyogenic bacterial infections, and autosomal recessive UNC93B1 and autosomal dominant TLR3 deficiencies were reported in 2006 and 2007, respectively, conferring predisposition to herpes simplex encephalitis. Furthermore, we highlight the published data associating TLR polymorphism with an altered susceptibility to infectious diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19430930     DOI: 10.1007/s12016-009-8135-0

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  68 in total

Review 1.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

2.  Toll-like receptor 4 polymorphisms and atherogenesis.

Authors:  Graham S Cooke; Shelley Segal; Adrian V S Hill
Journal:  N Engl J Med       Date:  2002-12-12       Impact factor: 91.245

3.  Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling.

Authors:  Amanda L Gavin; Kasper Hoebe; Bao Duong; Takayuki Ota; Christopher Martin; Bruce Beutler; David Nemazee
Journal:  Science       Date:  2006-12-22       Impact factor: 47.728

4.  Effect of recombinant human interferon alpha B/D (rHu-IFN-alpha B/D) in combination with acyclovir in experimental HSV-1 encephalitis.

Authors:  U Wintergerst; J D Gangemi; R J Whitley; S Chatterjee; E R Kern
Journal:  Antiviral Res       Date:  1999-11       Impact factor: 5.970

Review 5.  Herpes simplex virus infections.

Authors:  R J Whitley; B Roizman
Journal:  Lancet       Date:  2001-05-12       Impact factor: 79.321

Review 6.  Inherited human IRAK-4 deficiency: an update.

Authors:  Capucine Picard; Horst von Bernuth; Cheng-Lung Ku; Kun Yang; Anne Puel; Jean-Laurent Casanova
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

7.  Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation.

Authors:  Pierre-Yves Bochud; Jason W Chien; Kieren A Marr; Wendy M Leisenring; Arlo Upton; Marta Janer; Stephanie D Rodrigues; Sarah Li; John A Hansen; Lue Ping Zhao; Alan Aderem; Michael Boeckh
Journal:  N Engl J Med       Date:  2008-10-23       Impact factor: 91.245

Review 8.  The human model: a genetic dissection of immunity to infection in natural conditions.

Authors:  Jean-Laurent Casanova; Laurent Abel
Journal:  Nat Rev Immunol       Date:  2004-01       Impact factor: 53.106

Review 9.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

10.  Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity.

Authors:  Cheng-Lung Ku; Horst von Bernuth; Capucine Picard; Shen-Ying Zhang; Huey-Hsuan Chang; Kun Yang; Maya Chrabieh; Andrew C Issekutz; Coleen K Cunningham; John Gallin; Steven M Holland; Chaim Roifman; Stephan Ehl; Joanne Smart; Mimi Tang; Franck J Barrat; Ofer Levy; Douglas McDonald; Noorbibi K Day-Good; Richard Miller; Hidetoshi Takada; Toshiro Hara; Sami Al-Hajjar; Abdulaziz Al-Ghonaium; David Speert; Damien Sanlaville; Xiaoxia Li; Frédéric Geissmann; Eric Vivier; László Maródi; Ben-Zion Garty; Helen Chapel; Carlos Rodriguez-Gallego; Xavier Bossuyt; Laurent Abel; Anne Puel; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2007-09-24       Impact factor: 14.307

View more
  13 in total

1.  Modulation of IL-8 boosted by Mycoplasma pneumoniae lysate in human airway epithelial cells.

Authors:  Kyung Eun Lee; Kyung Won Kim; Jung Yeon Hong; Kyu Earn Kim; Myung Hyun Sohn
Journal:  J Clin Immunol       Date:  2013-06-19       Impact factor: 8.317

2.  Prior TLR5 induction in human T cells results in a transient potentiation of subsequent TCR-induced cytokine production.

Authors:  Mikaela M Tremblay; Mahmood Y Bilal; Jon C D Houtman
Journal:  Mol Immunol       Date:  2013-10-12       Impact factor: 4.407

3.  The future of autoimmunity.

Authors:  Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

4.  Gene expression profiling of peripheral blood mononuclear cells from children with active hemophagocytic lymphohistiocytosis.

Authors:  Janos Sumegi; Michael G Barnes; Shawnagay V Nestheide; Susan Molleran-Lee; Joyce Villanueva; Kejian Zhang; Kimberly A Risma; Alexei A Grom; Alexandra H Filipovich
Journal:  Blood       Date:  2011-02-16       Impact factor: 22.113

5.  Complete dependence on IRAK4 kinase activity in TLR2, but not TLR4, signaling pathways underlies decreased cytokine production and increased susceptibility to Streptococcus pneumoniae infection in IRAK4 kinase-inactive mice.

Authors:  Meghan E Pennini; Darren J Perkins; Andres M Salazar; Michael Lipsky; Stefanie N Vogel
Journal:  J Immunol       Date:  2012-12-03       Impact factor: 5.422

6.  Fatal pneumococcal meningitis in a 7-year-old girl with interleukin-1 receptor activated kinase deficiency (IRAK-4) despite prophylactic antibiotic and IgG responses to Streptococcus pneumoniae vaccines.

Authors:  Brianna McKelvie; Karina Top; Christine McCusker; Duncan Letenyi; Thomas B Issekutz; Andrew C Issekutz
Journal:  J Clin Immunol       Date:  2014-03-05       Impact factor: 8.317

7.  TRAF molecules in cell signaling and in human diseases.

Authors:  Ping Xie
Journal:  J Mol Signal       Date:  2013-06-13

8.  Controlling the response: predictive modeling of a highly central, pathogen-targeted core response module in macrophage activation.

Authors:  Jason E McDermott; Michelle Archuleta; Brian D Thrall; Joshua N Adkins; Katrina M Waters
Journal:  PLoS One       Date:  2011-02-14       Impact factor: 3.240

9.  cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms.

Authors:  Maria Feoktistova; Peter Geserick; Beate Kellert; Diana Panayotova Dimitrova; Claudia Langlais; Mike Hupe; Kelvin Cain; Marion MacFarlane; Georg Häcker; Martin Leverkus
Journal:  Mol Cell       Date:  2011-07-07       Impact factor: 17.970

Review 10.  Bacterial interference with canonical NFκB signalling.

Authors:  Mona Johannessen; Fatemeh Askarian; Maria Sangvik; Johanna E Sollid
Journal:  Microbiology       Date:  2013-07-19       Impact factor: 2.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.